It is co-owned 50:50 by Norways HL8government and the Finnish aerospace and defense company Patria.

have been the only long-lasting treatment.Gene therapy treatments can cost millions of dollars and experts have previously raised concerns that they could remain out of reach for the people who would benefit most.HL8

Britains regulator said its decision to authorize the gene therapy for sickle cell disease was based on a study done on 29 patients.Both sickle cell disease and thalassemia are caused by mistakes in the genes that carry hemoglobin.Jon LaPook has repoHL8rted on another effort to harness gene therapy to cure sickle cell disease.

Scientists believe being a carrier of the sickle cell trait helps protect against severe malaria.in a move that could offer relief to thousands of people with the crippling disease in the U.

Casgevy made by the Boston-based Vertex Pharmaceuticals (Europe) Ltd.

Casgevy is currently being reviewed by the U.Stockin says he has been wrongly accused and is innocent.

and we will not settle for anything less than a fair trial.or better supervised his patient interaction.

Stockin would not have been in a position to sexually abuse me and other patients.another Article 32 hearing will be convened on the new specifications.